Latest Advances

  • Condition: HDV-related compensated cirrhosis
  • Journal: Journal of hepatology
  • Treatment Used: High-dose myrcludex-B monotherapy combined with tenofovir disoproxil fumarate
  • Number of Patients: 3
  • Published —
The study reports cases of HDV-related compensated cirrhosis treated with high-dose myrcludex-B monotherapy combined with tenofovir disoproxil fumarate.
  • Condition: Hepatitis D Virus (HDV)
  • Journal: The Lancet. Infectious diseases
  • Treatment Used: Peginterferon Alfa-2a Combined with Tenofovir Disoproxil Fumarate (TDF)
  • Number of Patients: 120
  • Published —
This study examines whether extended treatment with peginterferon alfa-2a, over the course of 96 weeks, as well as the addition to treatment of tenofovir disoproxil fumarate (TDF) would be effective in reducing post-treatment relapses in patients with hepatitis D virus (HDV).
  • Condition: Chronic Hepatitis Delta (CHD)
  • Journal: Journal of medical virology
  • Treatment Used: Pegylated (PEG)-Interferon ? (IFN)
  • Number of Patients: 46
  • Published —
This analysis evaluated the outcomes of pegylated (PEG)-interferon ? (IFN) treatment in patients with chronic hepatitis delta (CHD).
Showing 1-3 of 3